Brought to you by 
Genta raises $29mm in private placement
11 Nov 2002
Executive Summary
Genta (antisense therapeutics) raised $28.9mm through a private placement of 4.3mm common shares at $6.74 each, a discount of (pr)24%. Institutional investors SAC Capital, Narragansett Capital, and Proquest Investments led the financing.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genta raises $29mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice